Skip to main content
Lidia Sánchez-Moral on Muck Rack

Lidia Sánchez-Moral

As seen in: Gut Journal, EBioMedicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Lidia

Contact Lidia, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Macrophage CD5L is a target for cancer immunotherapy

|
By Lidia Sánchez-Moral, Tony Paul, Departament de Farmacologia, Clara Martori
| EBioMedicine Verified
Summary Background Reprogramming of immunosuppressive tumor-associated macrophages (TAMs) presents an attractive therapeutic strategy in cancer. The aim of this study was to explore the role of macrophage CD5L protein in TAM activity and assess its potential as a therapeutic target. Methods Monoclonal antibodies (mAbs) against recombinant CD5L were raised by subcutaneous immunization of BALB/c mice.
Open in Who Shared Issue with article?

ZEB1 promotes inflammation and progression towards inflammation-driven carcinoma through repression of the DNA repair glycosylase MPG in epithelial cells

|
By Oriol de Barrios, Lidia Sánchez-Moral, Marlies Cortés, Chiara Ninfali
| Gut Journal Verified
Inflammatory bowel disease ZEB1 promotes inflammation and progression towards inflammation-driven carcinoma through repression of the DNA repair glycosylase MPG in epithelial cells Oriol de Barrios1, Lidia Sanchez-Moral1, Marlies Cortés1, Chiara Ninfali1, Nuria Profitós-Pelejà1, MC Martínez-Campanario1, Laura Siles1, Rosa del Campo2, María Jesús Fernández-Aceñero3, Douglas S Darling4, Antoni Castells5,6, Joan Maurel7, Azucena Salas5, Douglas C Dean8,9, Antonio Postigo1,9,10 1 Group of...
Open in Who Shared Issue with article?

ZEB1 promotes inflammation and progression towards inflammation-driven carcinoma through repression of the DNA repair glycosylase MPG in epithelial cells

|
By Oriol de Barrios, Lidia Sánchez-Moral, Marlies Cortés, Chiara Ninfali
| Gut Journal Verified
Inflammatory bowel disease ZEB1 promotes inflammation and progression towards inflammation-driven carcinoma through repression of the DNA repair glycosylase MPG in epithelial cells Oriol de Barrios1, Lidia Sanchez-Moral1, Marlies Cortés1, Chiara Ninfali1, Nuria Profitós-Pelejà1, MC Martínez-Campanario1, Laura Siles1, Rosa del Campo2, María Jesús Fernández-Aceñero3, Douglas S Darling4, Antoni Castells5,6, Joan Maurel7, Azucena Salas5, Douglas C Dean8,9, Antonio Postigo1,9,10 1Group of...
Open in Who Shared Issue with article?
See all 5 articles